← Back to Search

Other

Digital Medicine Arm for Chronic Hepatitis C (DASH Trial)

N/A
Waitlist Available
Led By Mark Sulkowski, MD
Research Sponsored by Proteus Digital Health, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 to 16 weeks (during therapy)
Awards & highlights
No Placebo-Only Group

Summary

This study evaluates the ability of digital medicines, Proteus Discover, to promote adherence and thus achieving a cure for hepatitis C in patients at high risk for not adhering to their hepatitis therapy. In this single-arm, prospective study, subjects at high risk for nonadherence will be prescribed hepatitis C therapy that will be co-encapsulated with ingestible sensors (creating the digital medicine) by a pharmacy. Both the subject and the providers will have access to the ingestion adherence.

Eligible Conditions
  • Chronic Hepatitis C
  • Noncompliance

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 to 16 weeks (during therapy)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 to 16 weeks (during therapy) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
SVR12 Rate
Secondary study objectives
Ingestion Adherence
SVR4 Rate
Safety Profile:Summary details of all adverse events during the study
+1 more
Other study objectives
Treatment efficiency

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Digital Medicine ArmExperimental Treatment1 Intervention
Subjects enrolled in this single arm study will be directed to use digital medicine versions of their hepatitis C therapy for the duration of therapy.

Find a Location

Who is running the clinical trial?

Proteus Digital Health, Inc.Lead Sponsor
10 Previous Clinical Trials
1,121 Total Patients Enrolled
Mark Sulkowski, MDPrincipal InvestigatorJohns Hopkins University
5 Previous Clinical Trials
1,080 Total Patients Enrolled
~31 spots leftby Nov 2025